XSHE
002870
Market cap742mUSD
Jul 10, Last price
37.80CNY
1D
-0.89%
1Q
3.34%
IPO
16.77%
Name
Guangdong Senssun Weighing Apparatus Group Ltd
Chart & Performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Founded in Zhongshan, China, in 1975, Guangdong Senssun Weighing Apparatus Group Ltd. (which operated as Senssun Weighing Apparatus Co., Ltd. until its 2008 rebranding) is a prominent producer of health and measurement solutions, primarily serving the Chinese market. The company provides a comprehensive range of household weighing devices, including scales for personal health, body fat analysis, kitchen use, electronic table models, weight counting, cashier applications, and spring dial mechanisms, alongside other commercial weighing equipment. Their innovative smart product line features intelligent body fat scales, smart food nutrition scales, wearable bracelets, smart baby scales, and digital coasters. These varied offerings are sold under several recognized brands such as Xiangshan, SENSSUN, CAMRY, Golden Leaf, Kangmei, and iFit, catering to both domestic consumers and commercial clients with professional measurement solutions. Furthermore, the company boasts a global reach, exporting its products to roughly 80 countries and regions spanning five continents.
Valuation
Title CNY in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2023‑00 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | |||||||||||
Revenues | |||||||||||
Cost of revenue | |||||||||||
Unusual Expense (Income) | |||||||||||
NOPBT | |||||||||||
NOPBT Margin | |||||||||||
Operating Taxes | |||||||||||
Tax Rate | |||||||||||
NOPAT | |||||||||||
Net income | |||||||||||
Dividends | |||||||||||
Dividend yield | |||||||||||
Proceeds from repurchase of equity | |||||||||||
BB yield | |||||||||||
| Debt | |||||||||||
Debt current | |||||||||||
Long-term debt | |||||||||||
Deferred revenue | |||||||||||
Other long-term liabilities | |||||||||||
Net debt | |||||||||||
| Cash flow | |||||||||||
Cash from operating activities | |||||||||||
CAPEX | |||||||||||
Cash from investing activities | |||||||||||
Cash from financing activities | |||||||||||
FCF | |||||||||||
| Balance | |||||||||||
Cash | |||||||||||
Long term investments | |||||||||||
Excess cash | |||||||||||
Stockholders' equity | |||||||||||
Invested Capital | |||||||||||
ROIC | |||||||||||
ROCE | |||||||||||
| EV | |||||||||||
Common stock shares outstanding | |||||||||||
Price | |||||||||||
Market cap | |||||||||||
EV | |||||||||||
EBITDA | |||||||||||
EV/EBITDA | |||||||||||
Interest | |||||||||||
Interest/NOPBT | |||||||||||